Research ArticleOriginal Research
Effect of Very-High-Flow Nasal Therapy on Airway Pressure and End-Expiratory Lung Impedance in Healthy Volunteers
Rachael L Parke, Andreas Bloch and Shay P McGuinness
Respiratory Care October 2015, 60 (10) 1397-1403; DOI: https://doi.org/10.4187/respcare.04028
Rachael L Parke
Cardiothoracic and Vascular Intensive Care Unit, Auckland City Hospital, Auckland, New Zealand.
Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia and the Medical Research Institute of New Zealand, Wellington, New Zealand.
RN PhDAndreas Bloch
Cardiothoracic and Vascular Intensive Care Unit, Auckland City Hospital, Auckland, New Zealand.
Department of Intensive Care Medicine, University Hospital (Inselspital) and University of Bern, Bern, Switzerland.
MDShay P McGuinness
Cardiothoracic and Vascular Intensive Care Unit, Auckland City Hospital, Auckland, New Zealand.
Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia and the Medical Research Institute of New Zealand, Wellington, New Zealand.
MB ChBIn this issue
Respiratory Care
Vol. 60, Issue 10
1 Oct 2015
Effect of Very-High-Flow Nasal Therapy on Airway Pressure and End-Expiratory Lung Impedance in Healthy Volunteers
Rachael L Parke, Andreas Bloch, Shay P McGuinness
Respiratory Care Oct 2015, 60 (10) 1397-1403; DOI: 10.4187/respcare.04028